Open Access

Table 3

ASP scoring function of molecular docking between PcyDHFR and PcyDHPS and its inhibitors.

Proteins Substrate/Inhibitors Variants of P. cynomolgi
Relative of docking score1
Wild-type Human Macaque ΔHuman ΔMacaque
PcyDHFR Pyrimethamine 37.14 (0.15) 37.46 (0.15) 37.20 (0.15) −0.32 −0.06
Cycloguanil 36.52 (0.15) 37.05 (0.15) 36.75 (0.15) −0.53 −0.23
Trimethoprim 36.00 (0.12) 36.30 (0.13) 35.45 (0.12) −0.30 0.55
P218 49.53 (0.14) 50.33 (0.14) 49.50 (0.14) −0.80 0.03
P65 45.87 (0.12) 45.50 (0.12) 45.76 (0.12) 0.37 0.11
WR99210 44.63 (0.11) 44.21 (0.11) 44.87 (0.11) 0.42 −0.24
PcyDHPS pABA 13.28 (0.10) 14.02 (0.10) 14.41 (0.11) −0.74 −1.12
Sulfadoxine 19.89 (0.06) 22.09 (0.07) 20.94 (0.07) −2.20 −1.05
Sulfamethoxazole 16.67 (0.07) 17.63 (0.07) 17.12 (0.07) −0.96 −0.46

Note: The value in parentheses describes a normalization scoring function by dividing it by the molecular weight of its inhibitors. 1represents a relative of its docking score with the wild-type.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.